Warning letters, 483s, Recalls, Import Alerts, Audit observations
The USFDA issued a Form 483 to Strides Pharma Sciences Ltd., Bangalore facility (FEI 3004554612)
Aurobindo’s Eugia Pharma Specialities Limited (FEI 3011960448), located at Shameerpet, India, has been classified OAI
The U.S. FDA has issued a Warning Letter to Simtra BioPharma Solutions following cGMP deviations
The USFDA has issued a Warning Letter to the Indian drug manufacturing facility of Patcos
The USFDA has classified Sun Pharma’s Baska (Halol) facility (FEI: 3002957541) as Official Action Indicated
An USFDA 483 to CDMO major Catalent’s Baltimore facility (FEI 3015558590) in US cite poor
FDA has published the USFDA Form 483 issued to sterile drug manufacturing facility of Fareva
Novo Nordisk’s Bloomington plant (FEI 3005949964, Catalent Indiana LLC) is classified OAI by USFDA in
FDA conducted an inspection at the Hetero Labs Ltd, Warehouse at Nakkapally Village, Vishakapatnam, Andra
In September 2025, the USFDA classified Sun Pharmaceutical Industries Ltd.’s Halol facility as OAI (Official
